Ming‐Shen Dai

1.8k total citations
71 papers, 771 citations indexed

About

Ming‐Shen Dai is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Ming‐Shen Dai has authored 71 papers receiving a total of 771 indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Oncology, 23 papers in Pulmonary and Respiratory Medicine and 12 papers in Molecular Biology. Recurrent topics in Ming‐Shen Dai's work include HER2/EGFR in Cancer Research (9 papers), Cancer Treatment and Pharmacology (9 papers) and Advanced Breast Cancer Therapies (7 papers). Ming‐Shen Dai is often cited by papers focused on HER2/EGFR in Cancer Research (9 papers), Cancer Treatment and Pharmacology (9 papers) and Advanced Breast Cancer Therapies (7 papers). Ming‐Shen Dai collaborates with scholars based in Taiwan, United States and China. Ming‐Shen Dai's co-authors include Ching‐Liang Ho, Yuguang Chen, Ping‐Ying Chang, Tsu‐Yi Chao, Jyh‐Cherng Yu, Guo‐Shiou Liao, Chia‐Hung Kao, Cheng‐Li Lin, Te‐Yu Lin and Huan-Ming Hsu and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Ming‐Shen Dai

66 papers receiving 755 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ming‐Shen Dai Taiwan 17 278 206 171 94 83 71 771
Tingting Liu China 16 361 1.3× 255 1.2× 169 1.0× 87 0.9× 103 1.2× 77 770
Hiroshi Wakui Japan 15 412 1.5× 233 1.1× 345 2.0× 74 0.8× 100 1.2× 42 816
Ding Yang China 12 234 0.8× 318 1.5× 212 1.2× 154 1.6× 60 0.7× 36 795
Feyyaz Özdemir Türkiye 13 217 0.8× 118 0.6× 97 0.6× 71 0.8× 44 0.5× 76 587
Çiğdem Erten Türkiye 17 444 1.6× 158 0.8× 220 1.3× 161 1.7× 51 0.6× 41 749
Mark Hong Lee South Korea 13 245 0.9× 383 1.9× 135 0.8× 176 1.9× 97 1.2× 63 904
Maria Vadiaka Greece 13 423 1.5× 140 0.7× 194 1.1× 44 0.5× 58 0.7× 37 697
S. Matthews United States 14 288 1.0× 276 1.3× 218 1.3× 43 0.5× 42 0.5× 41 747
Armando Patrizio Italy 17 273 1.0× 246 1.2× 133 0.8× 74 0.8× 100 1.2× 45 1.1k
Kenji Yoshida Japan 19 152 0.5× 233 1.1× 182 1.1× 69 0.7× 106 1.3× 57 838

Countries citing papers authored by Ming‐Shen Dai

Since Specialization
Citations

This map shows the geographic impact of Ming‐Shen Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming‐Shen Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming‐Shen Dai more than expected).

Fields of papers citing papers by Ming‐Shen Dai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming‐Shen Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming‐Shen Dai. The network helps show where Ming‐Shen Dai may publish in the future.

Co-authorship network of co-authors of Ming‐Shen Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Ming‐Shen Dai. A scholar is included among the top collaborators of Ming‐Shen Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming‐Shen Dai. Ming‐Shen Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Huang, Shih‐Wen, Yein‐Gei Lai, Yung‐Hsiang Chen, et al.. (2025). Syngeneic natural killer cell therapy activates dendritic and T cells in metastatic lungs and effectively treats low-burden metastases. eLife. 13. 1 indexed citations
3.
Xu, Binghe, Shusen Wang, Min Yan, et al.. (2024). Sacituzumab govitecan in HR+HER2− metastatic breast cancer: the randomized phase 3 EVER-132-002 trial. Nature Medicine. 30(12). 3709–3716. 14 indexed citations
4.
Dai, Ming‐Shen, Ta‐Chung Chao, Ta‐Chung Chao, et al.. (2023). Oral paclitaxel and encequidar in patients with breast cancer: a pharmacokinetic, safety, and antitumor activity study. Therapeutic Advances in Medical Oncology. 15. 2628416–2628416. 2 indexed citations
5.
Yu, Jyh‐Cherng, Huan-Ming Hsu, Chi-Hong Chu, et al.. (2023). The Risk of Breast Cancer between Western and Mediterranean Dietary Patterns. Nutrients. 15(9). 2057–2057. 19 indexed citations
6.
Chen, Tom Wei‐Wu, Ming‐Shen Dai, Ching‐Hung Lin, et al.. (2023). Plasma cell-free tumor DNA, PIK3CA and TP53 mutations predicted inferior endocrine-based treatment outcome in endocrine receptor-positive metastatic breast cancer. Breast Cancer Research and Treatment. 201(3). 377–385. 5 indexed citations
7.
Lin, Po‐Han, Ling‐Ming Tseng, Yi‐Hsuan Lee, et al.. (2022). Neoadjuvant afatinib with paclitaxel for triple-negative breast cancer and the molecular characteristics in responders and non-responders. Journal of the Formosan Medical Association. 121(12). 2538–2547. 11 indexed citations
8.
He, Zhijian, Christopher Jackson, Sanjeev Deva, et al.. (2022). Population pharmacokinetics for oral paclitaxel in patients with advanced/metastatic solid tumors. CPT Pharmacometrics & Systems Pharmacology. 11(7). 867–879. 4 indexed citations
9.
Yu, Jyh‐Cherng, Huan-Ming Hsu, Chi-Hong Chu, et al.. (2022). The impact of frailty on breast cancer outcomes: evidence from analysis of the Nationwide Inpatient Sample, 2005-2018.. PubMed. 12(12). 5589–5598. 10 indexed citations
10.
Lin, Kung‐Hung, Huan-Ming Hsu, Kuo‐Feng Hsu, et al.. (2021). Survival outcomes in elderly Taiwanese women according to breast cancer subtype and lymph node status: A single-center retrospective study. PLoS ONE. 16(12). e0261258–e0261258. 2 indexed citations
11.
Jackson, Christopher, Eva Segelov, Hans Prenen, et al.. (2021). Oral paclitaxel with encequidar compared to intravenous paclitaxel in patients with advanced cancer: A randomised crossover pharmacokinetic study. British Journal of Clinical Pharmacology. 87(12). 4670–4680. 11 indexed citations
12.
Chen, Yuguang, Hsueh-Hsing Pan, Ming‐Shen Dai, et al.. (2015). Impact of Comorbidity and Age on Determinants Therapeutic Strategies in Advanced Pancreatic Head Cancer Patients With Obstructive Jaundices. Medicine. 94(31). e1298–e1298. 7 indexed citations
13.
Chen, Yuguang, Te‐Yu Lin, Cheng‐Li Lin, et al.. (2015). Risk of Erectile Dysfunction in Transfusion-naive Thalassemia Men. Medicine. 94(13). e700–e700. 5 indexed citations
14.
Liu, Chang-Hsien, Chih-Yung Yu, Wei‐Chou Chang, et al.. (2015). Computed tomographic-guided percutaneous radiofrequency ablation with hydrodissection of hepatic malignancies in the subcapsular location: Evaluation of safety and technical efficacy. Journal of the Chinese Medical Association. 79(2). 93–100. 10 indexed citations
15.
Liao, Guo‐Shiou, Yu‐Ching Chou, Huan-Ming Hsu, Ming‐Shen Dai, & Jyh‐Cherng Yu. (2014). The prognostic value of lymph node status among breast cancer subtypes. The American Journal of Surgery. 209(4). 717–724. 28 indexed citations
16.
Liu, Chang-Hsien, Chih-Yung Yu, Wei‐Chou Chang, et al.. (2014). Radiofrequency Ablation of Hepatic Metastases: Factors Influencing Local Tumor Progression. Annals of Surgical Oncology. 21(9). 3090–3095. 7 indexed citations
17.
Chang, Hung, et al.. (2014). Gefitinib leads to complete resolution of postoperative cervical chyloma and chylothorax in a lung cancer patient.. PubMed. 100(2). e49–51. 1 indexed citations
18.
Chen, Yuguang & Ming‐Shen Dai. (2012). Man With Nausea and Vomiting. Annals of Emergency Medicine. 60(2). 241–250. 3 indexed citations
19.
Dai, Ming‐Shen, et al.. (2010). Recombinant E.coli LLO/OVA Induces Murine BMDCs Maturation via TLR4 and NOD1 Receptor and Promotes Specific Cytotoxic T Cell Immunity. Biomedical and Environmental Sciences. 23(5). 350–356. 4 indexed citations
20.
Chisholm, Edward J., Georges Vassaux, Pilar Martín‐Duque, et al.. (2009). Cancer-Specific Transgene Expression Mediated by Systemic Injection of Nanoparticles. Cancer Research. 69(6). 2655–2662. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tingting Liu Breakdown of academic impact, for papers by Hiroshi Wakui Breakdown of academic impact, for papers by Ding Yang Breakdown of academic impact, for papers by Feyyaz Özdemir Breakdown of academic impact, for papers by Çiğdem Erten Breakdown of academic impact, for papers by Mark Hong Lee Breakdown of academic impact, for papers by Maria Vadiaka Breakdown of academic impact, for papers by S. Matthews Breakdown of academic impact, for papers by Armando Patrizio Breakdown of academic impact, for papers by Kenji Yoshida
Rankless by CCL
2026